Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

This progressive lung disease transforms healthy tissue into stiff, scarred areas making breathing difficult. Learn the ...

Discover how Temple Lung Center’s innovative clinical trials provide early access to breakthrough treatments and enhanced ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas -- tiny clumps of immune cells that form in response to inflammation. It's the most inflammatory of the interstitial lung diseases ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas-tiny clumps of immune cells that form in response to ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

The Independent Data Monitoring Committee (IDMC) has recommended to continue study as planned as there are no safety concerns ...

GRI Bio is developing Natural Killer T cell modulators for treatment of inflammatory, fibrotic and autoimmune diseases. It reported the results from its continuing Phase 2a study demonstrating ...

Eric Cannon, PharmD, FAMCP, discusses how LPA1 receptor activation promotes fibrosis in idiopathic pulmonary fibrosis (IPF) ...

Rein advanced the clinical development of its lead asset, LTI-03, and aims to initiate a Phase 2 trial for the treatment of idiopathic pulmonary fibrosis (IPF) in the ...